Well Referenced

Tag: survival

Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherap

This 2018 multicenter observational study (PLoS ONE, PMID: 30148853) assessed the impact of adding Viscum album L. (mistletoe extract) to standard chemotherapy in 158 patients with stage IV non-small cell lung cancer (NSCLC). Patients who received mistletoe alongside chemotherapy had significantly improved median overall survival (17.0 vs. 8.0 months, p=0.007)

Read More »
June 26, 2025 No Comments

Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland

This multicenter, comparative cohort study evaluated the long-term use of fermented European mistletoe extract (Iscador) as an adjuvant therapy in patients with intermediate- to high-risk malignant melanoma (UICC/AJCC stage II-III). The treatment group, receiving subcutaneous mistletoe 2-3 times per week, showed improved tumor-related survival, better disease-free survival, and fewer brain

Read More »
June 26, 2025 No Comments